qualifications: geoffrey.dobson@jcu.edu.au
position: Professor, Heart and Trauma Research Laboratory
department: Medicine and Dentistry
Australia
Dr Geoffrey Dobson's research strategy at JCU exploits the August Krogh Principle, which states that: "for any question in science there is one animal best suited to study it". The approach involves tapping into hundreds of millions of years of animal adaptations in Nature's own laboratory, and developing new therapeutics to treat human disease. His innovations borrow from natural hibernators and include a new normokalemic 'polarizing' cardioplegia to stop the heart in cardiac surgery, which is currently used in the USA, and at lower doses developing a resuscitation fluid to rescue soldiers suffering catastrophic blood loss on the battlefield. The trauma targets are being developed in collaboration with the US military, and have clinical relevance in tropical, rural and remote prehospital and retrieval medicine. More recently, Dr Dobson's team is developing new applications to treat post-partum hemorrhage, which is the leading cause of direct and preventable death of women globally.
Commentary 23 January 2022
Community water fluoridation and child dental caries in remote NT
article
Prevalence and factors associated with sarcopenia in southern Brazil
article
Community events to increase uptake of Indigenous-specific health assessments
article
11th Biennial Pacific Region Indigenous Doctors Congress (PRIDoC) 2024, 2–6 December 2024, Kaurna Country, Adelaide, Australia
web link
Te Tāreitanga: Evolving understanding of health workforce research, 9 December 2024, Dunedin, NZ, and online
web link
4th International Indigenous Health & Wellbeing Conference 2025, 16–19 June 2025, Adelaide Convention Centre, Kaurna Country, Australia
web link